In vitro Antibacterial Effect of Hydroalcoholic Extract of Lawsonia inermis, Malva sylvestris, and Boswellia serrata on Aggregatibacter actinomycetemcomitans

Vahabi, Surena; Hakemi-Vala, Mojdeh; Gholami, Samaneh

In vitro Antibacterial Effect of Hydroalcoholic Extract of Lawsonia inermis, Malva sylvestris, and Boswellia serrata on Aggregatibacter actinomycetemcomitans

Authors

¹ Dental Research Center, Research Institute of Dental Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

² Department of Microbiology, Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran

³ Dentist, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background: Considering the increased rate of microbial resistance to antibiotics and chemical side effects of antibiotics and antiseptics used for the treatment of periodontal disease, there is a need for an alternative antimicrobial agent with fewer complications. Medicinal herbs have recently become popular as novel antimicrobial agents. This study aimed to assess the antibacterial effects of hydroalcoholic extracts of Lawsonia inermis, Malva sylvestris, and Boswellia serrata on Aggregatibacter actinomycetemcomitans. Materials and Methods: Hydroalcoholic extracts of the three medicinal plants were obtained by the maceration technique and A. actinomycetemcomitans was cultured. Antimicrobial efficacy of the three medicinal plants was compared with that of 0.2% chlorhexidine (CHX) according to the Clinical and Laboratory Standards Institute protocol using agar disc diffusion and broth microdilution techniques. All tests were repeated three times. Results: Hydroalcoholic extracts of all three plants had antimicrobial activity against A. actinomycetemcomitans. The minimum inhibitory concentration (MIC) of L. inermis, M. sylvestris, and B. serrata was 78.1, 156.2, and 1666 μg/mL with no significant difference between them. The MIC of CHX was 3.33 μg/mL, which was significantly higher than that of B. serrata extract. Conclusion: Given that further in vivo studies confirm other properties of these extracts and their safety in terms of cytotoxicity and mutagenicity, hydroalcoholic extracts of L. inermis and M. sylvestris may be used in mouthwashes or local delivery systems to affect periodontal biofilm.

Keywords

References

1.	Takei NC. Carranza's Clinical Periodontology. California: Julie Ed; 2015. p. 9, 49-51, 81-4, 161.
2.	Marsh PD. Microbiological aspects of the chemical control of plaque and gingivitis. J Dent Res 1992;71:1431-8.
3.	Hedayati A, Khosropanah H, Bazargani A, Abed M, Emami A. Assessing the antimicrobial effect of the essential oil of Myrtus communis on the clinical isolates of Porphyromonas gingivalis: An in vitro study. Jundishapur J Nat Pharm Prod 2013;8:165-8.
4.	. Kranti K, Seshan H, Zope S. Clinical evaluation of topical subgingival application of biodegradable xanthan based 1.5% Chlorhexidine gel for treatment of periodontal pockets. J Adv Dent Res 2010;1:47-54.
5.	Slots J, Feik D, Rams TE. Prevalence and antimicrobial susceptibility of Enterobacteriaceae, Pseudomonadaceae and Acinetobacter in human periodontitis. Oral Microbiol Immunol 1990;5:149-54.
6.	Van Winkelhoff AJ, Herrera D, Winkel EG, Dellemijn-Kippuw N, Vandenbroucke-Grauls CM, Sanz M, et al. Antibiotic resistance in the subgingival microflora in patients with adult periodontitis. A comparative survey between spain and the Netherlands. Ned Tijdschr Tandheelkd 1999;106:290-4.
7.	Lindhe JT, Nicklaus P. Clinical Periodontology and Implant Dentistry. 5^th ed. Munksgaard Copenhagen: Willey Blackwell; 2008. p. 106-16.
8.	Ciancio SG. Chemical agents: Plaque control, calculus reduction and treatment of dentinal hypersensitivity. Periodontol 2000 1995;8:75-86.
9.	Almas K. The effect of Salvadora persica extract (miswak) and chlorhexidine gluconate on human dentin: A SEM study. J Contemp Dent Pract 2002;3:27-35.
10.	Sudharameshwari K, Radhika J. Antibacterial screening of aegle marmelos, Lawsonia inermis and Albizzia libbeck. Afr J Tradit Complement Altern Med 2006;4:199-204.
11.	Malhotra R, Grover V, Kapoor A, Saxena D. Comparison of the effectiveness of a commercially available herbal mouthrinse with chlorhexidine gluconate at the clinical and patient level. J Indian Soc Periodontol 2011;15:349-52. [PUBMED] [Full text]
12.	Jeyaseelan EC, Jenothiny S, Pathmanathan MK, Jeyadevan JP. Antibacterial activity of sequentially extracted organic solvent extracts of fruits, flowers and leaves of Lawsonia inermis L. from Jaffna. Asian Pac J Trop Biomed 2012;2:798-802.
13.	Hemem S. Activity of Some Plant Extracts Against Common Pathogens in Bacterial Skin Infection: Thesis MSc, College of Education, Basra University, Iraq; 2002.
14.	Habbal OA, Al-Jabri AA, El-Hag AH, Al-Mahrooqi ZH, Al-Hashmi NA.In vitro antimicrobial activity of Lawsonia inermis linn (henna). A pilot study on the Omani Henna. Saudi Med J 2005;26:69-72.
15.	Imami A, Ahi A. Medical Botany. Mashhad: Mashhad University of Medical Sciences; 2015.
16.	Al-Rubiay KK, Jaber NN, Al-Mhaawe BH, Alrubaiy LK. Antimicrobial efficacy of henna extracts. Oman Med J 2008;23:253-6.
17.	Baxter H, Harborne JB, Moss GP. Phytochemical Dictionary: A Handbook of Bioactive Compounds from Plants. 2^nd Edition, Taylor & Francis, London 1999
18.	Kelmanson JE, Jäger AK, van Staden J. Zulu medicinal plants with antibacterial activity. J Ethnopharmacol 2000;69:241-6.
19.	Singh M, Jindal S, Kavia Z, Jangid B, Khem C. Traditional methods of cultivation and processing of henna. Henna, Cultivation, Improvement and Trade. Jodhpur: Central Arid Zone Research Institute, 2005, 21–24.
20.	Choubey A, Ojha M, Mishra A, Mishra S, Patil U. Hypoglycemic and antihyperglycemic effect of ethanolic extract of whole plant of Lawsonia inermis (henna) in streptozotocin induced diabetic rats. Int J Pharm Sci Rev Res 2010;1:74-7.
21.	Goswami M, Kulshreshtha M, Rao C, Yadav S, Yadav S. Anti ulcer potential of Lawsonia inermis leaf. Int J Pharm Sci Rev Res 2011;10:25-7.
22.	Rahmoun M, Benabdallah M, Villemin D, Boucherit K, Mostefa-Kara B, Ziani-Cherif C, et al. Antimicrobial screening of the Algerian Lawsonia inermis (henna). Pharm Chem 2010;2:320-6.
23.	Deshpande D. A Hand Book of Herbal Remedies. India: Agrobios; 2008. p. 287-9.
24.	Singh S, Shrivastava N, Modi N, Saifi A. Anti-inflammatory activity of Lawsonia inermis. Curr Sci 1982;51: 470-471.
25.	Kamal M, Jawaid T. Pharmacological activities of Lawsonia inermis Linn.: A review. Int J Biomed Res 2010;1:37-43.
26.	Akter A, Neela FA, Khan MS, Islam MS, Alam MF. Screening of ethanol, petroleum ether and chloroform extracts of medicinal plants, Lawsonia inermis L. and Mimosa pudica L. for antibacterial activity. Indian J Pharm Sci 2010;72:388-92.
27.	Gull I, Sohail M, Aslam MS, Amin Athar M. Phytochemical, toxicological and antimicrobial evaluation of lawsonia inermis extracts against clinical isolates of pathogenic bacteria. Ann Clin Microbiol Antimicrob 2013;12:36.
28.	Noori, M., M. Jafari and M. Zakeri, 2015. Root and aerial parts flavonoids of 3 Iranian Carex L. (Cyperaceae) species. Int. J Plant Res, 5: 51-56
29.	Gasparetto JC, Martins CA, Hayashi SS, Otuky MF, Pontarolo R. Ethnobotanical and scientific aspects of Malva sylvestris L.: A millennial herbal medicine. J Pharm Pharmacol 2012;64:172-89.
30.	Cutillo F, D'Abrosca B, Dellagreca M, Fiorentino A, Zarrelli A. Terpenoids and phenol derivatives from Malva silvestris. Phytochemistry 2006;67:481-5.
31.	Barros L, Carvalho AM, Ferreira IC. Leaves, flowers, immature fruits and leafy flowered stems of Malva sylvestris: A comparative study of the nutraceutical potential and composition. Food Chem Toxicol 2010;48:1466-72.
32.	Veshkurova O, Golubenko Z, Pshenichnov E, Arzanova I, Uzbekov V, Sultanova E, et al. Malvone A, a phytoalexin found in Malva sylvestris (family malvaceae). Phytochemistry 2006;67:2376-9.
33.	Razavi SM, Zarrini G, Molavi G, Ghasemi G. Bioactivity of Malva sylvestris L. a medicinal plant from Iran. Iran J Basic Med Sci 2011;14:574-9.
34.	Gürbüz I, Ozkan AM, Yesilada E, Kutsal O. Anti-ulcerogenic activity of some plants used in folk medicine of Pinarbasi (Kayseri, Turkey). J Ethnopharmacol 2005;101:313-8.
35.	Shen T, Lou HX. Bioactive constituents of myrrh and frankincense, two simultaneously prescribed gum resins in Chinese traditional medicine. Chem Biodivers 2008;5:540-53.
36.	Yauan G, Wahlqvist M, He G, Yang M, Li D. Natural products and anti-inflammatory activity. Asia Pac J Clin Nutr 2006;15:143.
37.	Raja AF, Ali F, Khan IA, Shawl AS, Arora DS, Shah BA. et al. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata. BMC Microbiol 2011;11:54.
38.	Safayhi H, Rall B, Sailer ER, Ammon HP. Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther 1997;281:460-3.
39.	Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP, et al. Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 1992;261:1143-6.
40.	Singh S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Johri RK, et al. The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats. Phytomedicine 2008;15:408-15.
41.	Etzel R. Use of Incense in the Treatment of Alzheimer's Disease. Google Patents; 1998.
42.	Tsukada T, Nakashima K, Shirakawa S. Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines. Biochem Biophys Res Commun 1986;140:832-6.
43.	Huang MT, Badmaev V, Ding Y, Liu Y, Xie JG, Ho CT, et al. Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors 2000;13:225-30.
44.	Gupta I, Gupta V, Parihar A, Gupta S, Lüdtke R, Safayhi H, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 1998;3:511-4.E
45.	Krieglstein CF, Anthoni C, Rijcken EJ, Laukötter M, Spiegel HU, Boden SE, et al. Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Int J Colorectal Dis 2001;16:88-95.
46.	Ravanan P, Singh SK, Rao GS, Kondaiah P. Growth inhibitory, apoptotic and anti-inflammatory activities displayed by a novel modified triterpenoid, cyano enone of methyl boswellates. J Biosci 2011;36:297-307.
47.	Flavin DF. A lipoxygenase inhibitor in breast cancer brain metastases. J Neurooncol 2007;82:91-3.
48.	Ammon HP, Mack T, Singh GB, Safayhi H. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med 1991;57:203-7.
49.	Raja AF, Ali F, Khan IA, Shawl AS, Arora DS. Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res Notes 2011;4:406.
50.	Benso B, Rosalen PL, Alencar SM, Murata RM. Malva sylvestris inhibits inflammatory response in oral human cells. An in vitro infection model. PLoS One 2015;10:e0140331.
51.	Kafshdar Goharian M. Evaluation the Antibacterial Effect of Organic Solution of Olibanum on Aggregabacter actinomycetemcomitans (in vitro study). Shahid Beheshti University; 2014.
52.	Weckesser S, Engel K, Simon-Haarhaus B, Wittmer A, Pelz K, Schempp CM, et al. Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance. Phytomedicine 2007;14:508-16.
53.	Valgas C, Souza SM, Smânia EF, Smânia A Jr. Screening methods to determine antibacterial activity of natural products. Braz J Microbiol 2007;38:369-80.
54.	Papageorgiou VP, Assimopoulou AN, Couladouros EA, Hepworth D, Nicolaou KC. The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angew Chem Int Ed Engl 1999;38:270-301.
55.	Bhuvaneswari K, Poongothai SG, Kuruvilla A, Raju BA. Inhibitory concentrations of Lawsonia innermis dry powder for urinary pathogens. Indian J Pharmacol 2002;34:260-3. [Full text]
56.	Hussain T, Arshad M, Khan S, Sattar H, Qureshi MS.In vitro screening of methanol plant extracts for their antibacterial activity. Pak J Bot 2011;43:531-8.
57.	Lin J. Comparision of disk diffusion ad, and broth microdilution for antimicrobial susceptibility testing of five chitosans. A Thesis Submitted to the Department of Food and Science, Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College; 2011.

Advanced Biomedical Research